Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Merck & Company (MRK)

80.605   -0.445 (-0.55%) 08-07 15:03
Open: 80.79 Pre. Close: 81.05
High: 80.96 Low: 80.03
Volume: 4,181,589 Market Cap: 203,869M
Merck & Co., Inc. provides healthcare solutions worldwide. It operates through Pharmaceutical and Animal Health segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 82.565 - 83.062 83.062 - 83.431
Low: 79.395 - 80.053 80.053 - 80.542
Close: 80.188 - 81.157 81.157 - 81.877

Technical analysis

as of: 2020-08-07 2:28:34 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 97.88     One year: 114.32
Support: Support1: 79.00    Support2: 76.04
Resistance: Resistance1: 83.80    Resistance2: 97.88
Pivot: 79.79
Moving Average: MA(5): 81.48     MA(20): 79.56
MA(100): 78.25     MA(250): 82.40
MACD: MACD(12,26): 0.80     Signal(9): 0.61
Stochastic oscillator: %K(14,3): 63.46     %D(3): 69.14
RSI: RSI(14): 54.83
52-week: High: 92.64  Low: 65.25  Change(%): -6.1
Average Vol(K): 3-Month: 956356  10-Days: 770855

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MRK has closed below upper band by 37.6%. Bollinger Bands are 37.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 07 Aug 2020
Bayer, Merck Can't Be Pulled Back In Leg Amputation Suit - Law360

Fri, 07 Aug 2020
NIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatment - MarketWatch

Fri, 07 Aug 2020
Merck snaps up Irish food traceability firm IdentiGEN -

Thu, 06 Aug 2020
Merck KGaA raises lower end of FY profit guidance range - Reuters UK

Wed, 05 Aug 2020
Merck enters agreement with Hanmi for investigational NASH drug - PMLiVE

Wed, 05 Aug 2020
Merck Animal Health Completes Acquisition of IdentiGEN - Business Wire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug ManufacturersGeneral
Shares Out. (M) 2,520
Shares Float (M) 2,520
% Held by Insiders 0.08
% Held by Institutions 78.55
Shares Short (K) 14,880
Shares Short P. Month (K) 15,810

Stock Financials

EPS 3.940
EPS Est This Year 3.870
EPS Est Next Year 4.160
Book Value (p.s.) 10.380
Profit Margin 21.10
Operating Margin 32.73
Return on Assets (ttm) 11.8
Return on Equity (ttm) 37.5
Qtrly Rev. Growth 11.5
Gross Profit (p.s.) 13.365
Sales Per Share 19.079
EBITDA (p.s.) 7.563
Qtrly Earnings Growth 10.40
Operating Cash Flow (M) 12,810
Levered Free Cash Flow (M) 9,000

Stock Valuations

PE Ratio 20.43
PEG Ratio 1.63
Price to Book value 7.76
Price to Sales 4.22
Price to Cash Flow 15.84

Stock Dividends

Dividend 2.260
Forward Dividend 2.440
Dividend Yield 0.03
Dividend Pay Date 2020-07-06
Ex-Dividend Date 2020-06-11
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.